$ZS

Geller Adam sold $345K of ZS

Geller Adam (Chief Product Officer) sold 2,817 shares of Zscaler, Inc. (ZS) at $122.60 ($0.35M total) on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Geller Adam
Published Jun 23, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and post-transaction holdings; however, the pre-arranged 10b5-1 plan reduces interpretive weight for near-term fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but it is unlikely to drive a fundamental repricing absent additional company catalysts.

03

What to watch

The filing does not disclose reasons for the sale beyond the plan structure; without concurrent news (earnings, guidance, major deals), the market impact should be treated as sentiment-only.

Relevance 3/10Novelty 3/10Timing: just-filed SEC Form 4 (filed 2026-06-23) for a 2026-06-22 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Zscaler, Inc. (ZS).

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

SEC Form 4 shows Zscaler CPO Adam Geller sold 2,817 shares at $122.60 on 2026-06-22 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a scheduled open-market sale under a pre-arranged 10b5-1 plan, with no accompanying company-specific news (guidance, contracts, litigation, or operational updates).

Market effects

Minimal; this is company-specific insider transaction with no sector-wide regulatory or demand signal.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations; traders may ignore it unless paired with other negative catalysts.

Key entities

  • Zscaler, Inc.

    Issuer of the Form 4 insider transaction; subject of the disclosure.

  • Adam Geller

    Chief Product Officer who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LITEMed

Why Cybersecurity Stocks Soared, AI Soured

AI companies like OpenAI and Anthropic expressed safety concerns, potentially slowing AI development. Shares of AI-related firms like Lumentum, Corning, Coherent, Dell, CoreWeave, Nebius, and HPE dropped. Meanwhile, cybersecurity stocks such as CrowdStrike, Zscaler, and Palo Alto Networks saw gains. Anthropic plans to IPO next month.

$ZSMedAI 8/10

Zscaler’s AI Story Is Accelerating, Its Growth Guide Isn’t

Zscaler (ZS) reported 25% ARR growth and $898M revenue for Q4, driven by AI demand. Management highlighted AI as a major growth driver, but fiscal 2027 guidance suggests growth may slow to 16.6-17.5%. The company cited sales transition and new-product adoption as factors. Total ARR reached $3.8B, with $246M in net new ARR. Non-GAAP operating margin was 24.3%.